Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multidrug-Resistant Bacterial Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05077813
What this trial is testing

Utilizing the Crosstalk Among Chicoric Acid, 13-Cis Retinoic Acid(Aerosolized), Minocycline and Vitamin D as a Potent Quadrate Therapy for Treating Patients With Multidrug-resistant TB and Patient With Both Multidrug-resistant TB and COVID-19

Who this might be right for
Tuberculosis
Kafrelsheikh University 250
Large-scale testing (Phase 3)Study completedNCT01977768
What this trial is testing

TB Immunotherapy Trial With Heat-killed M. Vaccae

Who this might be right for
Tuberculosis
Immunitor LLC 152
Not applicableStudy completedNCT07003581
What this trial is testing

Cardiometabolic Risk Factors Associated With Multidrug-Resistant Tuberculosis

Who this might be right for
Tuberculosis (TB)
B.P. Koirala Institute of Health Sciences 183
Not applicableUnknownNCT03967301
What this trial is testing

Prevention and Decolonization of Multidrug-resistant Bacteria With Probiotics

Who this might be right for
ProbioticsEnterobacteriaceae Infections
Hospital Italiano de Buenos Aires 228
Not applicableStudy completedNCT02169141
What this trial is testing

Pharmacokinetics of Levofloxacin and Capreomycin in Multidrug-Resistant Tuberculosis Patients

Who this might be right for
Tuberculosis
University Medical Center Groningen 20
Not applicableTemporarily pausedNCT01132417
What this trial is testing

In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance

Who this might be right for
Infections, Bacterial
King Faisal University 500
Large-scale testing (Phase 3)Not Yet RecruitingNCT07268664
What this trial is testing

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort

Who this might be right for
Rifampicin Resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more
Beijing Chest Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT07170800
What this trial is testing

A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets

Who this might be right for
TuberculosisMultidrug Resistant Pulmonary TuberculosisRifampicin-resistant Tuberculosis
WestVac Biopharma Co., Ltd. 60
Not applicableStudy completedNCT07058233
What this trial is testing

Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical Trial

Who this might be right for
Tuberculosis Multi Drug Resistant ActiveRifampin-Resistant Pulmonary TuberculosisPre-xdr tb
RSUP Persahabatan 70
Not applicableStudy completedNCT02852902
What this trial is testing

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.

Who this might be right for
Clinically Significant BacteremiaOrgan TransplantationInfection+6 more
Spanish Network for Research in Infectious Diseases 820
Large-scale testing (Phase 3)Looking for participantsNCT05081401
What this trial is testing

Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

Who this might be right for
Multidrug Resistant TuberculosisRifampicin Resistant TuberculosisPre-XDR-TB
Huashan Hospital 1,050
Early research (Phase 1)Study completedNCT02236078
What this trial is testing

Brief Bactericidal Activity of Anti-Tuberculosis Drugs

Who this might be right for
TuberculosisDrug-resistant TuberculosisIsoniazid Resistant Tuberculosis (Disorder)
Centers for Disease Control and Prevention 18
Not applicableStudy completedNCT02984579
What this trial is testing

Line Probe Assay Evaluation Study

Who this might be right for
Multidrug-Resistant TuberculosisIsoniazid Resistant Pulmonary TuberculosisRifampicin Resistant Tuberculosis+1 more
Foundation for Innovative New Diagnostics, Switzerland 888
Not applicableUnknownNCT05017324
What this trial is testing

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial

Who this might be right for
Rifampicin Resistant TuberculosisDrug-resistant TuberculosisMultidrug Resistant Tuberculosis+1 more
Universiteit Antwerpen 248
Not applicableStudy completedNCT03338738
What this trial is testing

Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria

Who this might be right for
Enterobacterial Infection
Fondation Hôpital Saint-Joseph 19
Not applicableStudy completedNCT02413931
What this trial is testing

Nosocomial Transmission of MDR-TB in Bucharest, Romania

Who this might be right for
Tuberculosis, Multidrug-resistant
Research Center Borstel 53
Not applicableStudy completedNCT05293418
What this trial is testing

Incidence of Colonization by Multidrug-resistant Organisms in Mechanically Ventilated Patients With Severe COVID-19

Who this might be right for
COVID-19Bacterial InfectionsColonization, Asymptomatic
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 435
Testing effectiveness (Phase 2)Study completedNCT04179500
What this trial is testing

A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+2 more
Global Alliance for TB Drug Development 26
Post-approval studies (Phase 4)Study completedNCT05278988
What this trial is testing

Ultrashort PRS Regimen V in the Treatment of MDR-TB

Who this might be right for
MDR-TB
Shanghai Pulmonary Hospital, Shanghai, China 60
Large-scale testing (Phase 3)Study completedNCT02342886
What this trial is testing

Shortening Treatment by Advancing Novel Drugs

Who this might be right for
Tuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant
Global Alliance for TB Drug Development 284
Next Page